SeekingAlpha · Aug 10, 2026
Gilead Sciences: The Market May Be Underestimating Its Growth (Rating Upgrade)
Gileadâs 2026 outlook improves as R&D pipeline accelerates and Biktarvy & Livdelzi sales rise, lifting guidance.
IP
OTC · IPSEY
Ipsen S.A.
Healthcare · Drug Manufacturers - Specialty & Generic
$49.15
Up+$0.00 (+0.00%)
Updated Sep 4, 2026, 4:24 PM
SID Score
7.5/10
Composite research score
Smart Money
46/100
Neutral
- Market cap
- 47.01B
- P/E ratio
- 22.47
- Dividend yield
- 0.81%
- 52-week range
- $25.11 – $51.10
- Volume
- 143
- Avg. volume
- 1.58K
Price performance
IPSEY price history
1M range · 8 trading sessions · Daily adjusted prices
IPSEY closed at $49.15 after 8 trading sessions, up 6.12% for the selected period.
- Last close
- $49.15
- Period change
- +6.12%
- Period low
- $45.03
- Period high
- $49.15
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 27, 2026 | $49.15 | $49.15 | $49.15 | $49.15 | 143 |
| Aug 20, 2026 | $47.60 | $47.60 | $47.60 | $47.60 | 1.38K |
| Aug 18, 2026 | $47.565 | $47.565 | $47.565 | $47.565 | 145 |
| Aug 14, 2026 | $45.10 | $45.10 | $45.10 | $45.10 | 367 |
| Aug 12, 2026 | $45.03 | $45.03 | $45.03 | $45.03 | 217 |
| Aug 11, 2026 | $45.285 | $45.285 | $45.285 | $45.285 | 240 |
| Aug 10, 2026 | $45.30 | $45.96 | $45.30 | $45.96 | 1.6K |
| Aug 6, 2026 | $46.315 | $46.315 | $46.315 | $46.315 | 224 |
Latest IPSEY news
The latest Smart Investors Daily articles mentioning IPSEY.
Stock researchCompany · Overview
IPSEY research
Overview
Company profile and research snapshot.
Company profile
IPSEN SA S/ADR
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- —
- Implied upside
- —
- Analysts
- 5
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jul 13, 2026 | ROTHSCHILD & CO REDBURN | Buy | — |
| Jul 12, 2026 | H.C. WAINWRIGHT & CO., LLC | Buy | — |
| Jul 7, 2026 | ESN/CIC MARKET SOLUTIONS | Buy | — |
| Jul 6, 2026 | BAADER EUROPE / ALPHAVALUE | Buy | — |
| Jun 7, 2026 | BAADER EUROPE / ALPHAVALUE | Buy | — |
News briefing
No generated briefing is available yet.
SeekingAlpha · Aug 1, 2026
Ipsen S.A. (IPSEY) Q2 2026 Earnings Call Transcript
Ipsen S.A. (IPSEY) Q2 2026 Earnings Call July 30, 2026 8:00 AM EDTCompany ParticipantsDavid Loew - MD, CEO & DirectorAymeric Le Chatelier - Executive VP...
SeekingAlpha · Jul 30, 2026
Ipsen S.A. 2026 Q2 - Results - Earnings Call Presentation
2026-07-30. The following slide deck was published by Ipsen S.A.
SeekingAlpha · Jul 10, 2026
Here's Why Ipsen S.A. Just Paid €700M For Memo Therapeutics AG
Ipsen S.A. delivered strong 1Q26 results, with 22.6% CER revenue growth and rare disease revenues up 125% CER, reinforcing execution momentum. Learn more about IPSEY stock here.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
